Shi L - Search Results

1

Changes in serum alpha fetoprotein in patients with recurrent hepatocellular carcinoma following hepatectomy.

Liu G, Wang K, Li J, Xia Y, Lu L, Wan X, Yan Z, Shi L, Lau WY, Wu M, Shen F. Liu G, et al. Among authors: shi l. J Gastroenterol Hepatol. 2015 Sep;30(9):1405-11. doi: 10.1111/jgh.12953. J Gastroenterol Hepatol. 2015. PMID: 25801981

2

Treatment of portal vein tumor thrombus of hepatocellular carcinoma with percutaneous laser ablation.

Lu ZH, Shen F, Yan ZL, Li J, Yang JH, Zong M, Shi LH, Wu MC. Lu ZH, et al. J Cancer Res Clin Oncol. 2009 Jun;135(6):783-9. doi: 10.1007/s00432-008-0513-0. Epub 2008 Nov 26. J Cancer Res Clin Oncol. 2009. PMID: 19034515

3

Overexpression of aspartyl-(asparaginyl)-beta-hydroxylase in hepatocellular carcinoma is associated with worse surgical outcome.

Wang K, Liu J, Yan ZL, Li J, Shi LH, Cong WM, Xia Y, Zou QF, Xi T, Shen F, Wang HY, Wu MC. Wang K, et al. Hepatology. 2010 Jul;52(1):164-73. doi: 10.1002/hep.23650. Hepatology. 2010. PMID: 20578260

4

Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and a monitor of recurrence of hepatocellular carcinoma after curative liver resection.

Zhang XF, Lai EC, Kang XY, Qian HH, Zhou YM, Shi LH, Shen F, Yang YF, Zhang Y, Lau WY, Wu MC, Yin ZF. Zhang XF, et al. Ann Surg Oncol. 2011 Aug;18(8):2218-23. doi: 10.1245/s10434-011-1613-7. Epub 2011 Feb 20. Ann Surg Oncol. 2011. PMID: 21336512

5

A case-control study of correlation between preoperative serum AFP and recurrence of hepatocellular carcinoma after curative hepatectomy.

Xia Y, Yan ZL, Xi T, Wang K, Li J, Shi LH, Wu MC, Shen F. Xia Y, et al. Hepatogastroenterology. 2012 Oct;59(119):2248-54. doi: 10.5754/hge11978. Hepatogastroenterology. 2012. PMID: 22366528

6

Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: a non-randomized comparative study.

Xi T, Lai EC, Min AR, Shi LH, Wu D, Xue F, Wang K, Yan Z, Xia Y, Shen F, Lau WY, Wu MC. Xi T, et al. Hepatogastroenterology. 2012 Jun;59(116):1198-203. doi: 10.5754/hge09654. Hepatogastroenterology. 2012. PMID: 22580673

7

Changes of serum alpha-fetoprotein and alpha-fetoprotein-L3 after hepatectomy for hepatocellular carcinoma: prognostic significance.

Zhang XF, Yin ZF, Wang K, Zhang ZQ, Qian HH, Shi LH. Zhang XF, et al. Hepatobiliary Pancreat Dis Int. 2012 Dec 15;11(6):618-23. doi: 10.1016/s1499-3872(12)60234-3. Hepatobiliary Pancreat Dis Int. 2012. PMID: 23232633

8

Loss of function of Notch1 identifies a poor prognosis group of early stage hepatocellular carcinoma following hepatectomy.

Liu J, Liu JF, Wang K, Yan ZL, Wan XY, Huang AM, Wang YZ, Li J, Xia Y, Shi LH, Jiao BH, Zhang Y, Shen F. Liu J, et al. Oncol Rep. 2015 Dec;34(6):3174-86. doi: 10.3892/or.2015.4300. Epub 2015 Sep 21. Oncol Rep. 2015. PMID: 26398566

9

A novel scoring system predicts adjuvant chemolipiodolization benefit for hepatocellular carcinoma patients after hepatectomy.

Huang LF, Xing X, Wu D, Xia Y, Li J, Wang K, Yan ZL, Wan XY, Shi LH, Yang T, Lau WY, Wu MC, Shen F. Huang LF, et al. Oncotarget. 2016 May 3;7(18):25493-506. doi: 10.18632/oncotarget.8333. Oncotarget. 2016. PMID: 27027439 Free PMC article.

10

Adjuvant therapy with capecitabine postpones recurrence of hepatocellular carcinoma after curative resection: a randomized controlled trial.

Xia Y, Qiu Y, Li J, Shi L, Wang K, Xi T, Shen F, Yan Z, Wu M. Xia Y, et al. Among authors: shi l. Ann Surg Oncol. 2010 Dec;17(12):3137-44. doi: 10.1245/s10434-010-1148-3. Epub 2010 Jul 3. Ann Surg Oncol. 2010. PMID: 20602260 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,377 results

Search Page

Filters